Efficacy of a tobacco quitline in active duty military and TRICARE beneficiaries

A randomized trial

Robert C. Klesges, Jon Owen Ebbert, G. Wayne Talcott, Fridtjof Thomas, Phyllis A. Richey, Catherine Womack, Ann Hryshko-Mullen, John Oh

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A higher proportion of military personnel than civilians smoke cigarettes. Few randomized trials of tobacco use interventions have been conducted in the U.S. military. We evaluated the efficacy of a tobacco quitline (QL) in 1298 active duty military personnel, their dependents, reservists, and retirees who smoke cigarettes. Participants were randomized to either a proactive (counselor-initiated) or reactive (participant-initiated) QL intervention for 8 weeks. The proactive condition included up to an 8-week supply of free nicotine replacement therapy, and the reactive condition included a 2-week supply. The primary outcome was 12-month smoking abstinence. The enrolled population was predominantly affiliated with the Air Force and Army. At the end of treatment, proactive treatment was associated with a greater odds of both prolonged (44.22% vs. 24.96%; odds ratio [OR] = 2.4, P <0.0001) and 7-day point prevalence (49.92% vs. 28.20%; OR = 2.5, P <0.0001) smoking abstinence, a difference that was maintained for prolonged smoking abstinence at 12 months (22.03% vs. 13.41%; OR = 1.8, P <0.0001). Our findings provide evidence that a proactive QL with nicotine replacement therapy is highly efficacious among Air Force and Army active duty and TRICARE beneficiaries and would provide an effective telephonic treatment option for this population of smokers.

Original languageEnglish (US)
Pages (from-to)917-925
Number of pages9
JournalMilitary Medicine
Volume180
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

Tobacco
Smoking
Odds Ratio
Military Personnel
Nicotine
Smoke
Tobacco Products
Air
Therapeutics
Tobacco Use
Population

ASJC Scopus subject areas

  • Medicine(all)
  • Public Health, Environmental and Occupational Health

Cite this

Efficacy of a tobacco quitline in active duty military and TRICARE beneficiaries : A randomized trial. / Klesges, Robert C.; Ebbert, Jon Owen; Talcott, G. Wayne; Thomas, Fridtjof; Richey, Phyllis A.; Womack, Catherine; Hryshko-Mullen, Ann; Oh, John.

In: Military Medicine, Vol. 180, No. 8, 01.08.2015, p. 917-925.

Research output: Contribution to journalArticle

Klesges, RC, Ebbert, JO, Talcott, GW, Thomas, F, Richey, PA, Womack, C, Hryshko-Mullen, A & Oh, J 2015, 'Efficacy of a tobacco quitline in active duty military and TRICARE beneficiaries: A randomized trial', Military Medicine, vol. 180, no. 8, pp. 917-925. https://doi.org/10.7205/MILMED-D-14-00513
Klesges, Robert C. ; Ebbert, Jon Owen ; Talcott, G. Wayne ; Thomas, Fridtjof ; Richey, Phyllis A. ; Womack, Catherine ; Hryshko-Mullen, Ann ; Oh, John. / Efficacy of a tobacco quitline in active duty military and TRICARE beneficiaries : A randomized trial. In: Military Medicine. 2015 ; Vol. 180, No. 8. pp. 917-925.
@article{87004872ebe64cd88b5470cd4b327d79,
title = "Efficacy of a tobacco quitline in active duty military and TRICARE beneficiaries: A randomized trial",
abstract = "A higher proportion of military personnel than civilians smoke cigarettes. Few randomized trials of tobacco use interventions have been conducted in the U.S. military. We evaluated the efficacy of a tobacco quitline (QL) in 1298 active duty military personnel, their dependents, reservists, and retirees who smoke cigarettes. Participants were randomized to either a proactive (counselor-initiated) or reactive (participant-initiated) QL intervention for 8 weeks. The proactive condition included up to an 8-week supply of free nicotine replacement therapy, and the reactive condition included a 2-week supply. The primary outcome was 12-month smoking abstinence. The enrolled population was predominantly affiliated with the Air Force and Army. At the end of treatment, proactive treatment was associated with a greater odds of both prolonged (44.22{\%} vs. 24.96{\%}; odds ratio [OR] = 2.4, P <0.0001) and 7-day point prevalence (49.92{\%} vs. 28.20{\%}; OR = 2.5, P <0.0001) smoking abstinence, a difference that was maintained for prolonged smoking abstinence at 12 months (22.03{\%} vs. 13.41{\%}; OR = 1.8, P <0.0001). Our findings provide evidence that a proactive QL with nicotine replacement therapy is highly efficacious among Air Force and Army active duty and TRICARE beneficiaries and would provide an effective telephonic treatment option for this population of smokers.",
author = "Klesges, {Robert C.} and Ebbert, {Jon Owen} and Talcott, {G. Wayne} and Fridtjof Thomas and Richey, {Phyllis A.} and Catherine Womack and Ann Hryshko-Mullen and John Oh",
year = "2015",
month = "8",
day = "1",
doi = "10.7205/MILMED-D-14-00513",
language = "English (US)",
volume = "180",
pages = "917--925",
journal = "Military Medicine",
issn = "0026-4075",
publisher = "Association of Military Surgeons of the US",
number = "8",

}

TY - JOUR

T1 - Efficacy of a tobacco quitline in active duty military and TRICARE beneficiaries

T2 - A randomized trial

AU - Klesges, Robert C.

AU - Ebbert, Jon Owen

AU - Talcott, G. Wayne

AU - Thomas, Fridtjof

AU - Richey, Phyllis A.

AU - Womack, Catherine

AU - Hryshko-Mullen, Ann

AU - Oh, John

PY - 2015/8/1

Y1 - 2015/8/1

N2 - A higher proportion of military personnel than civilians smoke cigarettes. Few randomized trials of tobacco use interventions have been conducted in the U.S. military. We evaluated the efficacy of a tobacco quitline (QL) in 1298 active duty military personnel, their dependents, reservists, and retirees who smoke cigarettes. Participants were randomized to either a proactive (counselor-initiated) or reactive (participant-initiated) QL intervention for 8 weeks. The proactive condition included up to an 8-week supply of free nicotine replacement therapy, and the reactive condition included a 2-week supply. The primary outcome was 12-month smoking abstinence. The enrolled population was predominantly affiliated with the Air Force and Army. At the end of treatment, proactive treatment was associated with a greater odds of both prolonged (44.22% vs. 24.96%; odds ratio [OR] = 2.4, P <0.0001) and 7-day point prevalence (49.92% vs. 28.20%; OR = 2.5, P <0.0001) smoking abstinence, a difference that was maintained for prolonged smoking abstinence at 12 months (22.03% vs. 13.41%; OR = 1.8, P <0.0001). Our findings provide evidence that a proactive QL with nicotine replacement therapy is highly efficacious among Air Force and Army active duty and TRICARE beneficiaries and would provide an effective telephonic treatment option for this population of smokers.

AB - A higher proportion of military personnel than civilians smoke cigarettes. Few randomized trials of tobacco use interventions have been conducted in the U.S. military. We evaluated the efficacy of a tobacco quitline (QL) in 1298 active duty military personnel, their dependents, reservists, and retirees who smoke cigarettes. Participants were randomized to either a proactive (counselor-initiated) or reactive (participant-initiated) QL intervention for 8 weeks. The proactive condition included up to an 8-week supply of free nicotine replacement therapy, and the reactive condition included a 2-week supply. The primary outcome was 12-month smoking abstinence. The enrolled population was predominantly affiliated with the Air Force and Army. At the end of treatment, proactive treatment was associated with a greater odds of both prolonged (44.22% vs. 24.96%; odds ratio [OR] = 2.4, P <0.0001) and 7-day point prevalence (49.92% vs. 28.20%; OR = 2.5, P <0.0001) smoking abstinence, a difference that was maintained for prolonged smoking abstinence at 12 months (22.03% vs. 13.41%; OR = 1.8, P <0.0001). Our findings provide evidence that a proactive QL with nicotine replacement therapy is highly efficacious among Air Force and Army active duty and TRICARE beneficiaries and would provide an effective telephonic treatment option for this population of smokers.

UR - http://www.scopus.com/inward/record.url?scp=84943554197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943554197&partnerID=8YFLogxK

U2 - 10.7205/MILMED-D-14-00513

DO - 10.7205/MILMED-D-14-00513

M3 - Article

VL - 180

SP - 917

EP - 925

JO - Military Medicine

JF - Military Medicine

SN - 0026-4075

IS - 8

ER -